No definition available.
Other specified/unspecified necrotizing vasculopathies
EFO MESH Endpoint Browser PheWeb
M13_NECROVASCNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
491 |
4. Check minimum number of eventsNone |
491 |
5. Include endpointsNone |
491 |
6. Filter based on genotype QC (FinnGen only) |
491 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified/unspecified necrotizing vasculopathies
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies (FG)
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3624 | 1976 | 1609 |
| Only index persons | 2728 | 1510 | 1218 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.05 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 61.78 | 62.38 | 60.96 |
| Only index persons | 59.20 | 59.37 | 58.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 491 | 264 | 227 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.10 |
| Median age at first event (years) | 57.30 | 54.54 | 60.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 442
- Matched controls
- 4419
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
301.9
254
*
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
133.2
121
*
L04AX01
ATC
azathioprine; systemic
35.8
111.8
146
60
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
12.1
86.2
175
226
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
79.6
74
*
H02AB06
ATC
prednisolone; systemic
7.0
74.6
338
1396
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.4
59.9
266
961
4476A
ICD-9 Finland
Other disorders of arteries and arterioles, Arteritis, unspecified
+∞
58.7
55
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
47.8
45
*
L04AA06
ATC
mycophenolic acid; systemic
28.0
46.0
63
26
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
+∞
44.5
42
*
M05BA04
ATC
alendronic acid; oral
6.8
41.1
114
214
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.4
36.1
84
120
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.2
36.0
85
124
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
35.9
34
*
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
35.9
34
*
L01AA01
ATC
cyclophosphamide; systemic
+∞
35.9
34
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
35.4
281
1445
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
34.8
33
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
6.7
34.8
96
176
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
11.1
34.2
67
70
PAW37
NOMESCO Finland
Biopsy of temporal artery
97.8
33.3
36
*
44698
ICD-8 Finland
Polyarteritis nodosa and allied conditions, Other
+∞
32.7
31
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.8
32.7
179
672
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
31.9
111
269
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.5
28.6
65
88
C03CA01
ATC
furosemide; systemic
3.3
28.3
201
899
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
27.5
28.0
38
15
R50.9
ICD-10 Finland
Fever, unspecified
4.4
27.9
115
328
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
27.4
26
*
H02AB07
ATC
prednisone; oral
4.1
26.6
119
365
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
26.3
25
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
7.1
25.8
66
107
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
25.2
24
*
N085, M318
ICD-10 Finland
NA
+∞
25.2
24
*
H02AB04
ATC
methylprednisolone; systemic
3.9
24.9
116
366
J01MA12
ATC
levofloxacin; systemic
3.5
24.3
139
518
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
12.1
24.0
44
40
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.9
24.0
52
65
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.2
23.7
67
124
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
32.0
23.1
30
10
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
11.0
22.9
44
44
M35.3
ICD-10 Finland
Polymyalgia rheumatica
13.8
21.6
37
29
J01FF01
ATC
clindamycin; systemic
2.9
21.3
166
757
P01BA02
ATC
hydroxychloroquine; oral
5.4
21.3
67
141
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
21.2
85
231
D69.0
ICD-10 Finland
Allergic purpura
31.8
20.8
27
9
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.4
20.4
80
213
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
9.8
19.3
39
43
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
19.0
102
354
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.5
18.9
71
180
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
18.9
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
18.8
134
568
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
104.5
18.7
20
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
198.0
18.7
19
*
TK800
NOMESCO Finland
Hemodialysis
10.8
18.2
35
35
ZX120
NOMESCO Finland
Intravenous
4.0
18.2
78
224
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
17.8
17
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.6
17.6
87
282
A11CC03
ATC
alfacalcidol; systemic
9.2
17.3
36
42
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
18.3
17.1
26
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.6
17.0
51
101
TGC00
NOMESCO Finland
Bronchial lavation
9.9
17.0
34
37
I77.6
ICD-10 Finland
Arteritis, unspecified
93.6
16.7
18
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.4
16.2
43
73
Z49.1
ICD-10 Finland
Extracorporeal dialysis
15.3
16.0
26
18
A12AA04
ATC
calcium carbonate; oral
11.0
15.9
30
29
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
15.9
37
52
N18.0
ICD-10 Finland
End-stage renal disease
16.5
15.9
25
16
L95.8
ICD-10 Finland
Other vasculitis limited to skin
62.3
15.9
18
*
H26.3
ICD-10 Finland
Drug-induced cataract
62.3
15.9
18
*
M31.6
ICD-10 Finland
Other giant cell arteritis
+∞
15.7
15
*
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
15.7
15
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
15.5
59
151
M13.9
ICD-10 Finland
Arthritis, unspecified
4.5
15.5
57
141
A02BC02
ATC
pantoprazole; systemic
2.4
15.5
311
2220
N18.8
ICD-10 Finland
Other chronic renal failure
8.0
15.5
35
47
J01MA14
ATC
moxifloxacin; systemic
3.8
15.3
69
206
A46
ICD-10 Finland
Erysipelas
3.1
15.0
91
339
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
14.7
101
411
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
14.7
14
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
14.7
14
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
10.6
14.2
27
27
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
14.0
113
505
B03XA02
ATC
darbepoetin alfa; parenteral
9.6
13.9
28
31
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
12.0
13.5
24
21
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.7
13.4
60
178
S97
ICPC
Chronic ulcer skin
4.7
13.3
46
107
A02BC01
ATC
omeprazole; systemic
2.3
13.2
151
809
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.4
12.8
65
213
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.0
12.7
52
143
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
12.6
12
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.7
12.5
21
16
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
20.8
12.5
18
9
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.3
12.5
33
56
N02AX02
ATC
tramadol; systemic, rectal
2.1
12.5
216
1383
ZXA10
NOMESCO Finland
Bilateral
2.5
12.5
109
505
N02AA05
ATC
oxycodone; systemic
2.7
12.3
90
376
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
12.2
41
93
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.3
12.2
37
75
C08CA05
ATC
nifedipine; systemic
4.1
11.9
47
125
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.4
11.8
35
69
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
11.8
118
587
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
11.5
11
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
11.4
48
135
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.5
11.4
29
47
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.1
11.4
161
936
Z94.0
ICD-10 Finland
Kidney transplant status
11.0
11.4
21
20
ZX108
NOMESCO Finland
Inhalation
25.8
11.2
15
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
11.1
25
34
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
11.1
70
265
V03AE01
ATC
polystyrene sulfonate; oral
14.4
11.1
18
13
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.0
11.1
44
118
NHQ40
NOMESCO Finland
Amputation of toe
7.2
11.0
26
38
V03AE02
ATC
sevelamer; oral
44.5
11.0
13
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
10.9
46
130
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
10.8
85
371
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.2
10.6
40
102
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
10.6
146
836
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.3
10.5
39
98
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
10.5
184
1160
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.3
10.5
27
45
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
10.5
10
*
ZZA00
NOMESCO Finland
Split skin graft
6.0
10.4
28
49
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.4
10.3
51
164
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
10.2
118
621
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
10.2
78
331
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
10.2
54
183
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
10.1
57
202
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
10.0
92
434
J01MA02
ATC
ciprofloxacin; systemic
1.9
9.9
193
1259
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.3
9.9
51
170
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
9.4
9
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
9.4
9
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
9.4
9
*
J01DB01
ATC
cefalexin; oral
2.1
9.4
361
2995
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.4
86
405
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.3
9.3
24
40
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.9
9.3
57
212
A41.9
ICD-10 Finland
Sepsis, unspecified
4.5
9.3
32
75
N03AX16
ATC
pregabalin; oral
2.2
9.2
113
607
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
9.2
33
81
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
9.1
103
537
J45.1
ICD-10 Finland
Nonallergic asthma
3.3
8.9
44
142
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
7.4
8.8
20
28
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
14.4
8.7
14
10
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
14.4
8.7
14
10
UJF32
NOMESCO Finland
Coloscopy
2.0
8.7
130
756
XG410
NOMESCO Finland
Flow-volume spirometry
4.6
8.7
29
66
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
8.6
16
16
DHA10
NOMESCO Finland
Biopsy of cavity of nose
10.3
8.6
16
16
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
10.3
8.6
16
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
8.5
56
218
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
8.5
89
446
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
8.4
8
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
8.4
8
*
127
Kela drug reimbursment
Transplant complication
7.3
8.3
19
27
205
Kela drug reimbursment
Chronic hypertension
1.9
8.2
142
874
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.0
8.1
19
28
JN4AD
NOMESCO Finland
Body CT examination
3.0
8.1
47
170
1XC02
NOMESCO Finland
NA
17.6
8.1
12
7
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
34.0
8.1
10
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
8.1
78
374
H02AB09
ATC
hydrocortisone; systemic
6.5
8.1
20
32
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.2
8.1
16
18
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
8.1
39
124
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
10.3
8.1
15
15
M04AA01
ATC
allopurinol; systemic
2.3
8.1
76
362
R06.0
ICD-10 Finland
Dyspnoea
2.0
8.0
122
712
NF1AA
NOMESCO Finland
Hip X-ray examination
2.8
8.0
53
206
B01AA03
ATC
warfarin; systemic
2.0
8.0
112
634
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
8.0
36
109
UDM02
NOMESCO Finland
Sinoscopy
6.3
7.9
20
33
J01AA02
ATC
doxycycline; systemic
1.9
7.9
340
2813
137
Kela drug reimbursment
Uraemia requiring dialysis
11.1
7.8
14
13
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
9.7
7.8
15
16
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.2
7.8
23
46
C08CA01
ATC
amlodipine; oral
1.8
7.8
167
1100
NGQ20
NOMESCO Finland
Amputation of lower leg
18.7
7.6
11
6
A02BC03
ATC
lansoprazole; oral
1.9
7.6
143
902
Z49.0
ICD-10 Finland
Preparatory care for dialysis
10.3
7.6
14
14
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.3
7.5
17
24
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.7
7.5
18
28
J01FA06
ATC
roxithromycin; oral
1.8
7.5
176
1192
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.8
7.5
20
36
L95.0
ICD-10 Finland
Livedoid vasculitis
81.4
7.4
8
*
L88
ICPC
Rheumatoid/seropositive arthritis
4.4
7.3
25
59
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
11.1
7.3
13
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
7.2
83
434
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
7.2
35
113
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
20.4
7.2
10
5
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
7.2
85
450
I50.0
ICD-10 Finland
Congestive heart failure
2.9
7.1
42
154
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.8
7.1
19
34
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.1
117
702
ZXA00
NOMESCO Finland
Right side
1.8
7.1
135
851
J05AB11
ATC
valaciclovir; oral
2.3
7.1
68
327
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
7.1
57
249
H04.10
ICD-10 Finland
Dry eye syndrome
2.6
7.0
52
219
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
7.0
69
336
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
7.7
6.9
15
20
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.5
6.9
14
17
3AC01
NOMESCO Finland
NA
8.5
6.9
14
17
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
8.5
6.9
14
17
R04.0
ICD-10 Finland
Epistaxis
2.7
6.9
45
177
L04AA01
ATC
[U] ciclosporin; systemic
6.3
6.8
17
28
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.0
6.8
38
133
L93.0
ICD-10 Finland
Discoid lupus erythematosus
40.7
6.8
8
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
40.7
6.8
8
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.6
6.7
16
25
R53
ICD-10 Finland
Malaise and fatigue
2.0
6.7
99
569
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
12.5
6.6
11
9
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
12.5
6.6
11
9
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
12.5
6.6
11
9
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
10.2
6.6
12
12
WW200
NOMESCO Finland
Immunization
4.6
6.6
21
47
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
5.5
6.5
18
34
B05DA
ATC
Isotonic solutions
14.6
6.4
10
7
GD2SN
NOMESCO Finland
Lung ventilation SPECT
14.6
6.4
10
7
M05BA07
ATC
risedronic acid; oral
3.8
6.4
25
68
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.5
6.4
28
84
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
6.3
47
197
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.7
6.3
26
74
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.2
6.3
22
54
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
18.3
6.3
9
5
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.3
6.3
9
5
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
18.3
6.3
9
5
A41.8
ICD-10 Finland
Other specified sepsis
7.2
6.3
14
20
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
+∞
6.3
6
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
6.3
6
*
N085, M319
ICD-10 Finland
NA
+∞
6.3
6
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
6.3
6
*
J01DA01
ATC
[U] cefalexin; systemic
1.7
6.2
272
2169
TAB00
NOMESCO Finland
Lumbar puncture
3.6
6.2
26
75
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
6.2
40
156
N19
ICD-10 Finland
Unspecified kidney failure
4.2
6.2
22
55
J32.4
ICD-10 Finland
Chronic pansinusitis
7.8
6.2
13
17
H65.2
ICD-10 Finland
Chronic serous otitis media
7.8
6.2
13
17
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
12.7
6.1
10
8
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
6.1
65
328
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.1
63
314
J01CF05
ATC
flucloxacillin; systemic
3.6
6.0
25
72
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
6.0
25
72
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
124
86
18.95
143.42
6.1
1.1
iu/ml
13.3
—
—
28
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
106
65
20.52
129.88
3.2
1.1
titre
361.4
—
—
14
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
82
58
16.77
92.54
7.5
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
83
98
9.99
66.86
3.2
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
177
464
5.40
66.35
1.8
1.3
titre
722.8
384.9
1.23
58
98
(3005719) IgG [Mass/volume] in Serum or Plasma
135
289
6.06
63.24
5.4
2.8
g/l
9.3
10.5
2.02
130
266
(3015171) Extractable nuclear Ab [Units/volume] in Serum
81
114
8.31
56.38
1.5
1.1
u/ml
0.6
2.7
—
6
10
(3003458) Phosphate [Moles/volume] in Serum or Plasma
169
488
4.76
55.17
13.8
5.7
mmol/l
1.1
1.0
1.56
160
450
(3028026) IgM [Mass/volume] in Serum or Plasma
111
231
5.92
53.01
2.1
1.7
g/l
0.9
1.5
2.27
105
212
(42870588) Differential panel, method unspecified - Blood
289
1273
4.09
52.08
15.1
5.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
64
10.14
48.73
4.8
7.3
iu/ml
214.2
143.1
—
9
8
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
40
24
18.06
48.40
1.8
1.2
titre
407.5
70.0
—
12
6
(3006315) Basophils [#/volume] in Blood
355
1915
4.08
45.07
17.2
5.1
e9/l
0.0
0.0
0.04
339
1671
(3022096) Basophils/100 leukocytes in Blood
335
1739
3.92
45.06
17.7
5.3
%
0.6
0.7
0.68
328
1621
(3001604) Monocytes [#/volume] in Blood
354
1907
4.07
45.01
17.2
5.1
e9/l
0.6
0.6
3.04
338
1657
(3019069) Monocytes/100 leukocytes in Blood
342
1804
3.95
44.80
18.2
5.6
%
8.6
8.6
0.13
335
1694
(3020630) Protein [Mass/volume] in Serum or Plasma
119
304
4.85
44.43
2.0
3.1
g/l
64.7
66.6
1.45
113
277
(3018010) Neutrophils/100 leukocytes in Blood
342
1818
3.90
43.95
17.0
5.3
%
62.3
57.9
9.09
335
1703
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
40
29
14.93
43.83
2.6
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
339
1794
3.87
43.81
17.8
5.3
%
2.6
2.8
1.30
332
1671
(3013115) Eosinophils [#/volume] in Blood
359
1981
4.02
43.34
18.3
5.4
e9/l
0.2
0.2
0.02
344
1756
(3019198) Lymphocytes [#/volume] in Blood
356
1958
3.98
43.09
17.4
5.2
e9/l
1.7
1.9
1.48
341
1744
(3002030) Lymphocytes/100 leukocytes in Blood
342
1846
3.81
42.28
17.9
5.5
%
23.6
27.1
7.91
335
1716
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
56
72
8.65
41.69
1.4
1.2
u/ml
1.9
2.8
—
8
8
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
56
73
8.53
41.21
1.4
1.2
u/ml
19.7
3.1
0.60
13
11
(3004789) Transferrin [Mass/volume] in Serum or Plasma
163
565
3.82
39.93
5.4
2.4
g/l
2.1
2.3
4.29
158
519
(3004588) Protein electrophoresis panel - Serum or Plasma
101
247
4.89
39.49
1.8
3.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
156
537
3.79
38.43
5.5
2.4
%
22.7
22.1
0.20
140
467
(3023368) Bacteria identified in Blood by Culture
241
1110
3.30
37.13
7.4
4.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
167
621
3.56
36.34
5.3
2.4
umol/l
11.9
12.9
0.90
162
571
(3024980) IgG subclass 4 [Mass/volume] in Serum
45
52
9.43
36.32
2.0
1.9
g/l
0.6
0.8
0.42
31
42
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
30
12.49
34.64
1.4
1.4
g/l
2.7
2.5
0.12
24
23
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
30
12.49
34.64
1.4
1.4
g/l
0.4
0.4
0.25
24
23
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
30
12.49
34.64
1.4
1.4
g/l
6.8
6.0
0.44
24
23
(3013650) Neutrophils [#/volume] in Blood by Automated count
369
2248
3.58
34.41
19.2
8.6
e9/l
4.8
4.1
4.68
357
1968
(4062490)
34
32
11.34
31.65
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
283
1559
2.92
29.81
3.5
2.2
nmol/l
78.7
76.8
0.57
266
1367
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
167
4.88
29.66
2.0
1.6
g/l
1.7
1.5
0.82
63
150
(3007853) Bacteria identified in Skin by Aerobe culture
130
464
3.45
29.49
2.9
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
58
115
5.59
28.53
1.7
1.5
iu/ml
0.0
0.1
—
10
27
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
62
131
5.27
28.43
3.0
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
100
308
3.82
28.28
7.7
3.9
%
0.8
1.0
0.29
37
106
(3021440) Promyelocytes/100 leukocytes in Blood
95
284
3.91
28.03
7.9
4.0
%
0.1
0.2
0.85
35
94
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
325
1971
2.92
27.83
16.1
6.8
mmol/l
1.2
1.2
0.40
271
1665
(3002179) Metamyelocytes/100 leukocytes in Blood
92
273
3.92
27.40
7.3
3.9
%
0.4
0.4
0.07
27
75
(3017143) Hepatitis C virus Ab [Presence] in Serum
114
392
3.49
27.25
2.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
96
298
3.76
26.76
9.2
3.7
ng/l
151.7
81.8
2.90
90
266
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
15
16.04
26.39
1.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
259
1431
2.71
26.01
9.2
3.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
126
478
3.20
25.53
5.2
2.3
%
1.9
1.8
0.67
116
440
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
111
5.34
25.47
2.2
4.5
mg/l
30.0
30.5
0.03
43
91
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
111
5.34
25.47
4.8
2.3
u/ml
0.3
0.3
0.11
34
55
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
111
5.34
25.47
2.2
4.5
mg/l
47.0
104.6
0.51
41
91
(3024561) Albumin [Mass/volume] in Serum or Plasma
291
1727
2.68
24.94
9.7
4.7
g/l
33.2
35.5
8.55
279
1609
(3000850) Epithelial cells [#/volume] in Urine
179
840
2.78
24.55
7.4
2.5
e6/l
4.1
4.9
0.55
169
746
(3004616) Nuclear Ab [Presence] in Serum
30
34
9.33
24.42
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
65
163
4.44
24.17
2.3
2.1
u/l
37.7
38.7
0.13
59
145
(3023520) Reticulocytes [#/volume] in Blood
102
354
3.37
23.80
3.5
2.4
e9/l
70.8
68.9
0.21
80
281
(3026782) Osmolality of Urine
170
788
2.77
23.75
7.3
2.7
mosm/kgh2o
515.4
565.4
2.61
157
668
(3025159) Blasts/100 leukocytes in Blood
85
264
3.68
23.52
8.5
4.1
%
0.2
0.1
0.12
31
78
(3007164) IgA [Mass/volume] in Serum or Plasma
161
730
2.79
23.43
2.1
1.4
g/l
2.4
2.5
0.28
129
441
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
295
1806
2.59
23.03
14.9
5.9
mmol/l
1.2
1.2
1.44
279
1618
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
20
12.02
22.39
2.9
2.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
64
168
4.23
22.38
3.3
1.8
ug/l
1.2
3.3
0.63
59
146
(3011412) CD3 cells [#/volume] in Blood
27
30
9.47
22.27
2.8
1.9
e9/l
1.0
1.2
0.29
18
14
(40760888) Immunoglobulin light chains.free panel - Serum
42
78
5.79
22.05
2.3
4.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
37
61
6.48
21.88
1.5
1.2
u/ml
20.0
5.9
—
7
6
(3012095) Magnesium [Moles/volume] in Serum or Plasma
143
629
2.80
21.86
4.8
3.4
mmol/l
0.8
0.8
0.25
131
588
(46235355) HIV 1 and 2 tests - Meaningful Use set
134
572
2.85
21.66
2.4
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
220
1215
2.47
20.85
8.9
3.2
e6/l
31.1
120.4
0.98
198
941
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
486
2.91
20.80
2.4
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
20
11.47
20.79
2.8
2.0
%
16.0
12.4
—
9
12
(3042936) Bacteria identified in Isolate by Culture
134
584
2.78
20.73
3.3
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
147
674
2.69
20.57
2.2
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
144
4.26
20.07
1.4
3.1
g/l
3.5
3.7
0.34
39
104
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
63
6.09
20.06
2.4
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
145
4.23
19.89
1.4
3.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
145
4.23
19.89
1.4
3.0
g/l
7.8
7.3
0.87
39
110
(3018095) Leukocytes [#/volume] in Urine
240
1403
2.39
19.74
10.1
3.6
e6/l
47.5
127.0
1.79
198
1009
(3030905) Polymorphonuclear cells [#/volume] in Blood
35
62
6.00
19.26
5.9
2.3
e9/l
4.5
4.5
0.01
35
62
(3037756) Immunofixation for Serum or Plasma
40
81
5.29
19.10
1.3
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
132
4.29
18.94
1.4
3.2
g/l
9.7
10.5
0.41
46
113
(3026493) Urate [Moles/volume] in Serum or Plasma
188
1002
2.42
18.88
4.4
2.6
umol/l
2031.5
8424.7
1.98
175
857
(40768446) Kidney Pathology biopsy report
17
12
14.64
18.56
1.6
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
65
5.72
18.34
6.1
2.8
%
62.3
57.8
0.98
35
65
(3013707) Erythrocyte sedimentation rate by Westergren method
392
2911
2.72
18.09
13.2
3.7
mm/h
17.8
12.4
7.06
379
2669
(3021879) Hepatitis B virus core Ab [Presence] in Serum
75
253
3.32
18.08
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
57
5.94
17.49
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
59
174
3.72
17.46
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
87
328
3.01
17.36
11.6
8.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
52
141
4.01
17.32
3.3
3.2
g/l
0.4
0.3
0.63
29
50
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
109
466
2.72
17.21
2.2
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
288
1892
2.26
17.16
7.7
3.6
estimate
0.0
0.0
0.00
65
348
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
73
5.24
17.15
1.5
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
370
2706
2.49
17.06
10.0
4.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
163
847
2.38
17.02
2.0
1.7
mg/l
1.5
1.2
0.62
131
661
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
108
463
2.71
16.94
2.1
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
96
387
2.84
16.94
7.8
3.5
mmol/l
1.6
1.9
0.30
84
309
(3030467) Casts [#/volume] in Urine by Automated count
196
1109
2.28
16.72
8.9
3.0
e6/l
0.2
0.5
3.30
174
832
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
206
1194
2.25
16.53
3.1
2.0
u/l
128.2
205.4
2.82
197
1118
(36304419) Bacteria [Presence] in Urine
190
1068
2.27
16.40
8.6
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
204
1182
2.24
16.35
11.1
3.8
ph
7.4
7.4
0.55
47
209
(3021601) Nitrite [Presence] in Urine by Test strip
286
1901
2.21
16.20
10.3
5.0
estimate
0.0
0.0
0.50
70
345
(3032080) INR in Blood by Coagulation assay
259
1660
2.19
16.03
15.3
9.4
inr
1.3
1.3
0.62
77
464
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
55
5.74
15.91
2.0
1.4
u/ml
123.7
100.4
—
8
8
(3017817) Protein [Mass] in Urine collected for unspecified duration
23
32
7.49
15.80
2.0
3.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
137
3.86
15.62
1.4
3.1
g/l
3.4
3.0
1.87
39
107
(3009261) Glucose [Presence] in Urine by Test strip
287
1929
2.17
15.56
7.9
3.7
estimate
0.0
0.0
0.50
70
335
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
57
5.54
15.32
1.5
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
65
5.20
15.20
1.5
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
206
1229
2.16
15.05
3.9
3.1
ng/l
2231.4
1446.2
1.35
184
1045
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
40
99
4.31
15.01
1.6
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
34
7.05
14.98
2.4
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
56
5.44
14.55
1.4
1.2
u/ml
2.8
5.0
—
10
23
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
104
473
2.52
14.28
7.8
8.2
kpa
4.9
5.1
1.28
98
455
(3027801) Oxygen [Partial pressure] in Arterial blood
104
473
2.52
14.28
7.8
8.2
kpa
11.7
12.0
0.28
98
457
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
37
6.47
13.86
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
59
5.16
13.75
1.3
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
57
192
3.23
13.67
6.9
3.2
mmol/l
23.9
24.0
0.18
50
177
(3001122) Ferritin [Mass/volume] in Serum or Plasma
250
1649
2.05
13.59
5.6
2.7
ug/l
176.6
130.0
2.88
234
1506
(40760892) CBC W Ordered Manual Differential panel - Blood
152
832
2.20
13.56
12.6
4.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
81
4.44
13.38
1.2
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
172
994
2.12
13.31
3.5
2.1
mg/l
3.5
3.2
0.54
150
846
(3012516) Albumin [Mass/volume] in Urine
192
1158
2.08
13.25
7.0
3.2
mg/l
385.7
226.8
0.27
141
742
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
301
2137
2.06
13.20
6.3
6.1
umol/l
10.0
11.1
1.69
292
2018
(3003396) Base excess in Arterial blood by calculation
102
476
2.44
13.18
8.1
8.2
mmol/l
1.1
1.2
0.06
78
374
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
78
4.46
13.12
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
43
5.82
13.01
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
199
1224
2.05
12.96
7.1
3.1
mmol/l
6.8
7.5
1.55
177
1003
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
292
2.76
12.91
2.0
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
55
5.14
12.78
1.4
1.2
u/ml
229.7
254.8
0.20
20
33
(40758558) Short blood count panel - Blood
167
967
2.10
12.76
13.8
6.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
57
202
3.06
12.54
5.6
3.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
139
757
2.17
12.41
1.9
1.7
nmol/l
1297.3
1175.7
0.60
120
582
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
65
251
2.83
12.27
6.1
3.4
mmol/l
1.4
1.6
0.21
55
194
(3009343) pH of Capillary blood
67
267
2.75
11.91
6.2
3.3
ph
7.4
7.4
—
6
27
(3044290) Cell count panel - Cerebral spinal fluid
30
71
4.44
11.90
1.9
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
250
1703
1.95
11.87
23.2
8.7
e9/l
0.0
0.0
0.45
229
1393
(3042631) Mycobacterium sp identified in Specimen
26
55
4.94
11.79
1.9
3.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
99
3.84
11.72
1.6
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
64
4.58
11.59
4.6
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
115
595
2.22
11.58
1.3
1.2
iu/ml
27.7
43.5
1.31
38
183
(3017704) Immunofixation for Urine
15
18
8.56
11.55
1.3
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
27
6.88
11.54
2.3
1.9
e6/l
749.3
557.0
—
6
10
(3013826) Glucose [Moles/volume] in Serum or Plasma
316
2346
1.97
11.46
8.1
4.9
mmol/l
7.0
6.8
0.69
302
2193
(3044927) Protein electrophoresis panel - Urine
21
38
5.73
11.26
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
93
3.85
11.16
1.7
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
194
1233
1.95
11.12
9.4
3.9
mg/mmol
34.1
8.7
3.93
145
767
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
89
3.90
11.04
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
80
4.07
11.01
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
80
4.07
11.01
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
67
4.37
10.96
1.7
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
118
636
2.13
10.64
5.9
2.9
e6/l
3.7
2.2
0.76
82
347
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
23
7.16
10.63
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
19
33
5.95
10.61
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
25
56
4.65
10.60
3.8
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
104
3.55
10.20
1.8
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
38
5.44
10.19
1.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
42
5.18
10.13
1.9
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
42
5.18
10.13
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
54
4.62
10.12
1.8
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
96
3.61
9.92
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
5
26.63
9.86
5.7
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
428
2.26
9.79
4.8
3.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
334
2595
1.90
9.77
8.1
4.6
e6/l
123.5
2333.7
—
8
42
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
19
7.56
9.74
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
147
884
1.95
9.68
6.7
3.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
40
5.17
9.65
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
44
4.94
9.62
3.2
3.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
23
6.70
9.40
1.1
1.0
u/l
1.2
1.2
—
8
14
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
23
6.70
9.40
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
185
1211
1.85
9.32
3.8
3.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
164
1036
1.88
9.23
9.0
3.8
estimate
0.0
0.0
0.50
65
337
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
227
1592
1.79
9.04
5.4
3.7
ng/l
61.6
64.4
0.04
170
1135
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
35
5.30
8.95
1.3
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
51
205
2.66
8.88
9.0
10.1
mmol/l
24.6
24.5
0.06
46
193
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
28
5.87
8.85
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
104
571
2.04
8.79
1.3
1.2
u/ml
8.6
15.1
0.44
42
215
(21494814) CD8 cells/100 lymphocytes in Specimen
12
6
20.45
8.50
2.7
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
19
7.00
8.48
2.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
58
4.11
8.43
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
37
5.01
8.42
1.2
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
88
462
2.10
8.36
1.9
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
30
5.48
8.26
2.3
2.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
23
6.24
8.22
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
34
5.14
8.19
1.9
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
7
17.53
8.11
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
7
17.53
8.11
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
7
17.53
8.11
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
7
17.53
8.11
1.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
14
24
5.98
7.89
1.3
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
24
5.98
7.89
1.5
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
52
4.17
7.88
1.5
1.2
u/ml
4.5
6.0
—
6
16
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
21
6.33
7.75
1.6
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
115
683
1.89
7.66
6.1
2.7
e6/l
0.9
1.1
0.57
82
390
(40761535) Cells panel - Urine sediment
67
327
2.21
7.63
7.0
3.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
6
18.71
7.63
2.9
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
62
293
2.28
7.63
5.5
6.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
103
3.15
7.60
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
25
5.74
7.58
1.9
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
45
4.35
7.54
1.1
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
12
9
13.63
7.42
5.8
5.2
%
60.6
40.8
—
12
9
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
19
6.45
7.27
2.0
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
42
4.41
7.27
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
30
5.13
7.23
1.9
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
34
4.83
7.21
1.6
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
16
7.01
7.17
1.1
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
57
269
2.27
7.03
7.4
3.2
g/l
116.0
127.4
3.09
57
264
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
20
6.13
6.93
2.0
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
8
14.03
6.92
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
29
99
3.05
6.81
1.4
1.3
—
—
—
0
0
(44790048)
18
45
4.11
6.68
1.3
1.5
—
—
—
0
0
(44790047)
18
45
4.11
6.68
1.3
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
45
4.11
6.68
4.7
3.9
—
—
—
0
0
(44790049)
18
45
4.11
6.68
1.3
1.5
—
—
—
0
0
(44806118)
18
45
4.11
6.68
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
79
3.28
6.66
1.8
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
55
3.75
6.54
1.3
1.1
—
—
—
0
0
(4268621)
16
37
4.44
6.54
2.4
2.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
47
211
2.36
6.50
8.0
3.6
mmol/l
24.3
25.0
0.71
47
205
(3000475) Leukocytes [#/volume] in Synovial fluid
26
87
3.10
6.32
1.8
1.6
e6/l
2390.8
21056.8
1.98
19
66
(4027681)
12
22
5.57
6.31
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
5
18.30
6.28
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
77
3.23
6.25
3.4
2.3
%
15.7
16.0
0.09
11
39
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
30
4.77
6.25
2.2
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
31
117
2.76
6.11
4.3
3.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
16
6.36
5.97
1.2
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
29
107
2.82
5.96
6.9
2.4
mmol/l
24.1
24.8
0.40
29
90
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
201
1481
1.60
5.94
8.9
3.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
6
15.24
5.92
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
51
248
2.18
5.86
2.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
20
5.60
5.83
1.5
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
215
1616
1.59
5.81
2.3
2.0
pmol/l
95.1
94.1
0.13
118
855
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
121
2.67
5.74
1.7
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
61
321
2.03
5.71
3.1
3.2
ng/l
247.6
223.9
0.15
56
289
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
37
4.15
5.66
1.5
1.4
%
58.8
69.8
—
9
27
(3024928) Oxygen saturation in Venous blood
26
93
2.90
5.66
4.2
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
88
2.94
5.60
6.2
2.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
33
4.34
5.59
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
260
2.12
5.57
3.8
2.7
e9/l
4.8
3.9
1.32
40
206
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
21
5.34
5.55
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
247
2.14
5.52
1.7
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
1360
1.58
5.40
3.7
3.3
mmol/l
2.3
2.4
3.73
165
1197
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
264
2.08
5.36
1.9
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
99
2.72
5.07
1.4
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
19
5.35
5.06
1.4
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
36
3.97
5.02
1.2
1.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
45
222
2.13
5.00
7.2
2.4
%
1.2
1.2
0.06
45
222
(3019150) Specific gravity of Urine by Refractometry
125
850
1.63
4.99
8.0
4.0
kg/l
1.0
1.0
0.46
18
124
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
60
331
1.93
4.92
4.4
2.6
ml/min/173m2
51.0
63.6
1.38
36
140
(3019225) pH of Specimen
68
394
1.84
4.80
8.8
4.2
—
—
—
0
0
(3024471) HLA-A [Type]
8
7
11.59
4.80
1.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
8
7
11.59
4.80
1.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
7
11.59
4.80
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
173
1282
1.54
4.75
4.0
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
172
1274
1.54
4.73
4.3
3.3
u/l
39.0
32.6
0.50
166
1211
(3041096) Erythrocytes [Presence] in Urine by Automated
146
1044
1.57
4.69
8.2
3.3
—
—
—
0
0
(3020891) Body temperature
36
167
2.25
4.65
9.8
4.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
43
3.57
4.65
1.1
1.6
—
—
—
0
0
(4306422)
16
48
3.41
4.64
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
48
250
2.02
4.63
2.8
2.4
—
16.4
—
0
11
(3019174) dRVVT (LA screen)
7
5
14.17
4.59
1.1
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
34
3.90
4.56
1.1
1.1
u/l
42.3
53.6
—
7
23
(3003327) Ova and parasites identified in Stool by Light microscopy
28
118
2.46
4.48
2.4
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
6
11.81
4.28
1.1
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
6
11.81
4.28
1.1
1.0
%
87.6
99.3
—
7
6
(3048689) Calprotectin [Mass/mass] in Stool
73
449
1.74
4.22
2.9
2.2
ug/g
173.0
124.0
0.82
65
351
(3021788) Differential panel - Synovial fluid
18
62
2.98
4.21
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
62
2.98
4.21
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
24
97
2.55
4.19
1.7
1.2
—
58.0
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
52
3.15
4.12
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
14
6.53
4.00
2.2
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
119
2.34
3.95
1.4
1.3
iu/l
30.5
26.7
0.25
21
102
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
59
2.95
3.93
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
71
2.74
3.87
1.6
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
34
3.59
3.79
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
5
12.12
3.77
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
33
163
2.10
3.69
2.2
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
91
2.48
3.69
1.6
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
12
6.76
3.68
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
12
6.76
3.68
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
165
2.07
3.58
2.3
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
26
3.91
3.53
3.6
3.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
13
6.24
3.51
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
13
6.24
3.51
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
6
6
10.10
3.50
1.3
1.0
mg/g
9.2
6.1
—
6
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
6
10.10
3.50
1.3
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
31
3.61
3.50
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
775
1.52
3.50
4.7
4.0
ng/l
449.5
285.3
0.28
92
618
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
18
5.07
3.38
1.7
1.6
%
102.8
96.0
—
9
18
(3021960) Folate [Moles/volume] in Serum or Plasma
130
967
1.47
3.34
1.9
1.5
nmol/l
19.2
21.2
0.75
120
815
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
812
1.49
3.26
1.8
1.7
pmol/l
422.8
8533371.9
0.50
99
668
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
28
3.62
3.21
2.4
1.2
u/ml
1.4
0.1
—
10
14
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
15
5.40
3.20
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
425
3931
1.60
3.20
42.0
14.3
mg/l
25.1
23.7
0.41
409
3122
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
11
6.44
3.19
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
11
6.44
3.19
1.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
11
6.44
3.19
1.4
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
11
6.44
3.19
1.1
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
11
6.44
3.19
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
55
2.78
3.18
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
55
2.78
3.18
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
55
2.78
3.18
1.3
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
44
3.01
3.16
1.2
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
56
2.73
3.08
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
56
2.73
3.08
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
56
2.73
3.08
1.3
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
16
5.06
3.06
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
45
2.94
3.04
1.7
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
12
5.90
3.03
1.1
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
19
81
2.40
3.02
5.2
1.6
%
75.0
61.1
2.09
19
81
(44806071)
5
5
10.08
2.98
1.2
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.08
2.98
1.2
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
59
377
1.64
2.98
2.4
2.5
u/l
34.1
31.3
0.39
54
314
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
172
1.92
2.89
2.0
1.8
—
—
—
0
0
(3000492) Spirometry study
55
349
1.65
2.86
1.6
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
18
4.50
2.80
1.6
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
18
4.50
2.80
1.6
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
466
1.56
2.78
2.8
2.7
umol/l
9.5
7.5
0.39
58
409
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
42
2.90
2.77
1.2
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
194
1592
1.36
2.76
2.4
2.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
6
8.40
2.75
1.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
6
8.40
2.75
1.2
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
6
8.40
2.75
1.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
6
8.40
2.75
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
6
8.40
2.75
1.2
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
6
8.40
2.75
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
72
2.41
2.75
3.4
3.3
nmol/l
0.7
0.8
0.45
12
61
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
83
586
1.50
2.74
1.6
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
10
6.06
2.70
2.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
73
2.38
2.68
5.3
2.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
20
93
2.20
2.64
4.8
2.3
kpa
8.1
8.0
0.03
20
83
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
55
2.59
2.63
1.0
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
979
1.40
2.63
3.5
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
67
458
1.54
2.57
1.4
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
7
7.20
2.55
1.4
3.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
10
33
3.07
2.54
2.2
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
158
1.89
2.54
1.9
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
203
1.78
2.52
1.5
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
219
1.75
2.49
14.1
11.5
—
—
—
0
0
(3013512) EKG study
149
1189
1.36
2.49
5.4
4.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
16
4.42
2.48
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
12
5.05
2.41
1.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
12
5.05
2.41
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
8
6.30
2.37
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
8
6.30
2.37
1.2
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
50
327
1.59
2.33
13.3
3.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
53
2.49
2.29
1.2
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
1.1
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
23
3.52
2.28
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
23
3.52
2.28
1.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
8
23
3.52
2.28
1.9
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
9
5.60
2.22
2.0
2.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
36
2.81
2.21
3.2
1.6
%
10.7
10.8
—
10
36
(3045788) Cell count panel - Pleural fluid
10
36
2.81
2.21
2.6
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
54
365
1.54
2.19
2.6
2.4
ug/l
5.3
7.6
0.84
45
324
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
19
3.72
2.16
3.4
1.7
ug/l
77.2
61.9
—
7
19
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
14
4.32
2.15
1.0
1.0
miu/ml
1231.0
1556.9
—
6
14
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
106
820
1.37
2.13
1.4
1.2
u/ml
0.8
1.7
0.99
31
219
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
217
1866
1.29
2.08
6.0
4.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
15
4.04
2.04
1.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
15
4.04
2.04
4.8
3.5
%
289.7
109.6
—
6
15
(36660697) Celiac disease serology panel - Serum
43
282
1.58
2.00
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
319
0.52
1.98
1.2
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
11
4.58
1.94
1.2
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
11
4.58
1.94
1.2
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
52
2.34
1.89
3.8
1.8
pg
30.3
32.8
0.80
12
52
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
322
2933
1.28
1.88
4.3
3.8
pmol/l
15.1
14.9
0.81
300
2624
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
34
2.68
1.87
2.1
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
17
3.56
1.84
2.7
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
17
3.56
1.84
2.7
3.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
17
3.56
1.84
1.2
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
12
4.20
1.82
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
53
2.30
1.82
2.0
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
23
3.07
1.80
1.7
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
29
2.79
1.80
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
24
2.94
1.73
6.0
2.9
—
—
—
0
0
(4198724)
5
13
3.87
1.72
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
306
2786
1.26
1.71
4.2
3.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
42
2.41
1.68
6.3
2.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
16
84
1.94
1.61
1.3
1.2
u/l
14.6
9.7
—
10
67
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
505
1.38
1.59
5.0
4.6
%
32.0
31.7
0.07
54
329
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
50
2.23
1.58
1.3
1.3
nmol/l
0.8
0.5
0.97
11
45
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
141
0.42
1.54
1.7
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
108
1.79
1.53
2.5
2.5
ug/min
150.8
105.0
0.20
14
62
(4035726)
48
344
1.44
1.52
1.3
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
116
1.75
1.51
1.8
1.4
ug/g
312.4
275.1
0.54
15
68
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
45
2.25
1.47
1.3
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
22
2.75
1.44
1.0
1.0
—
10.2
—
0
5
(3047189) Immunofixation for 24 hour Urine
6
22
2.75
1.44
1.0
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
46
2.20
1.40
1.3
1.3
nmol/l
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
254
2301
1.22
1.35
3.2
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
280
2561
1.22
1.35
3.9
3.1
u/l
60.8
52.3
0.93
268
2381
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
363
3826
0.80
1.31
5.4
4.6
mmol/l
6.0
6.0
0.14
340
3459
(4010399)
40
286
1.43
1.30
1.7
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
95
777
1.28
1.30
2.6
2.9
mmol/l
2.5
2.5
0.57
84
685
(3012441) Differential panel - Pleural fluid
9
45
2.02
1.24
2.3
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
14
78
1.82
1.22
1.6
1.9
u/l
3389.4
4519.2
—
8
27
(3022621) pH of Urine by Test strip
37
265
1.43
1.20
4.7
3.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
39
2.07
1.15
2.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
112
0.44
1.14
4.2
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
40
2.02
1.12
1.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
41
1.97
1.09
1.8
1.1
mosm/kgh2o
269.6
279.5
—
8
28
(40768797) Stomach Pathology biopsy report
66
528
1.29
1.09
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
59
1.88
1.08
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.4
—
1.7
—
0
22
(3051611) Lipemic interference index of Serum or Plasma
7
36
1.96
0.97
6.0
2.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
50
1.81
0.97
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
31
418
0.72
0.96
1.7
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
325
1.32
0.90
1.7
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
421
4079
1.23
0.83
32.3
13.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
117
1324
0.85
0.83
3.4
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
236
0.67
0.82
1.6
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
47
1.71
0.81
1.1
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
385
3704
1.18
0.80
31.0
13.4
ml/min/173m2
71.3
79.2
6.27
344
3036
(3044941) Cell count panel - Synovial fluid
10
58
1.74
0.80
1.9
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
11
67
1.66
0.75
1.5
1.2
u/l
93.5
22.7
0.60
11
58
(3001019) Free T4 and TSH panel - Serum or Plasma
10
160
0.62
0.75
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
310
0.73
0.74
1.7
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
109
0.54
0.73
1.7
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
238
1.32
0.72
1.6
1.2
iu/ml
73.8
167.0
2.05
16
100
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
296
1.27
0.66
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
87
1.51
0.64
16.1
3.9
mg/l
36.0
34.4
—
7
51
(3032773) Endomysium IgG Ab [Titer] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
122
1.41
0.61
5.4
5.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
208
0.71
0.59
1.5
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
23
0.00
0.58
0.0
2.1
—
7.2
—
0
17
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
377
3652
1.14
0.57
7.9
5.9
mmol/mol
41.2
40.1
1.21
364
3373
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
36
296
1.23
0.53
1.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
200
1.26
0.47
2.8
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
77
1.44
0.46
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
17
0.00
0.40
0.0
1.5
—
68.5
—
0
12
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
17
0.00
0.40
0.0
1.4
—
1.3
—
0
12
(3014051) Protein [Presence] in Urine by Test strip
12
88
1.37
0.40
3.8
2.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.4
—
126.7
—
0
18
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.7
—
7.5
—
0
9
(3035637) Corticotropin [Mass/volume] in Plasma
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
67
1.35
0.38
5.4
2.6
mmol/l
106.0
105.5
—
9
67
(3041354) Potassium [Moles/volume] in Venous blood
9
67
1.35
0.38
5.4
2.6
mmol/l
4.1
4.1
—
9
67
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
376
3842
0.91
0.37
5.5
4.4
mmol/l
1.5
1.5
0.20
353
3510
(40768800) Prostate Pathology biopsy report
5
77
0.65
0.36
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
19
153
1.25
0.36
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
79
0.63
0.35
1.6
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
124
0.72
0.35
2.0
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
366
3576
1.09
0.35
5.2
4.6
mu/l
1.9
2.3
0.62
344
3225
(3000330) Specific gravity of Urine by Test strip
25
210
1.20
0.33
7.1
4.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
101
1.29
0.32
1.7
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
53
1.33
0.31
3.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
66
1.22
0.27
6.0
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
66
1.22
0.27
1.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
55
506
1.10
0.23
18.5
6.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
524
0.91
0.23
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
101
0.79
0.21
1.3
1.3
—
—
—
0
0
(44806420)
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
3867
0.95
0.18
5.4
4.5
mmol/l
4.5
4.6
0.58
357
3557
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
391
3953
0.95
0.16
5.8
5.0
mmol/l
2.6
2.7
2.07
373
3605
(4094501)
12
102
1.18
0.15
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
123
1.14
0.12
1.9
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
17
189
0.90
0.12
1.4
1.1
—
111.8
—
0
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
367
3703
0.96
0.11
5.1
4.0
mmol/l
1.4
1.3
1.85
346
3362
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
104
1071
0.96
0.10
3.5
4.4
%
21.2
21.6
0.15
50
511
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
183
1.10
0.10
1.6
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
125
1.12
0.10
1.9
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
448
1.05
0.09
1.6
1.7
%
1.7
1.5
0.65
41
385
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
154
0.91
0.08
1.9
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
76
1.05
0.07
3.3
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
349
3515
0.98
0.07
35.1
15.7
%
37.7
39.7
2.99
226
2475
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
88
1.02
0.07
2.6
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
287
1.05
0.05
2.1
2.1
nmol/l
13.2
13.3
0.02
23
259
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
78
764
1.02
0.05
2.7
3.0
ug/l
0.7
0.8
0.35
56
501
(3016879) Cocaine [Presence] in Urine
11
101
1.09
0.04
2.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
134
1353
0.99
0.03
4.0
5.0
ug/l
2.4
2.6
0.16
116
1197
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
122
1.07
0.02
1.8
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
437
0.98
0.01
2.1
4.2
ug/l
3.9
35.3
1.08
34
370
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1043
1.01
0.01
1.7
1.6
mmol/l
1.5
1.4
0.49
92
860
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
186
0.97
0.00
1.2
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
124
0.97
0.00
1.1
1.1
—
—
—
0
0
(4034850)
14
143
0.98
0.00
15.4
9.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
98
1.02
0.00
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
108
1.02
0.00
2.6
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
108
1.02
0.00
2.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
108
1.02
0.00
2.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
108
1.02
0.00
2.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
105
1047
1.00
0.00
1.4
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
51
510
1.00
0.00
1.5
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
61
0.98
0.00
5.0
2.1
u/ml
5.3
5.2
—
6
56
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
16.4
—
0
7
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.3
—
74.8
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
97.1
—
0
6
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.9
—
0
7
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
32.1
—
0
5
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_NECROVASCNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_NECROVASCNAS | 2.738 [2.25, 3.33] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.152 |
During the follow-up period (1.1.1998 — 31.12.2019), 421 out of 1141 females with M13_NECROVASCNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_NECROVASCNAS | 2.719 [2.19, 3.38] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 382 out of 930 males with M13_NECROVASCNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_NECROVASCNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.155% | 0.461% |
| 5 | 1.405% | 3.089% |
| 10 | 3.493% | 7.542% |
| 15 | 7.111% | 14.245% |
| 20 | 12.552% | 22.975% |
Relationships between endpoints
↥Index endpoint: M13_NECROVASCNAS – Other specified/unspecified necrotizing vasculopathies
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data